Invited Faculty
  • Ian Bruce
    The Univ. of Manchester
    UK
  • Ian Bruce is Professor of Rheumatology and Vice Dean for Health and Care Partnerships, Faculty of Biology, Medicine and Health, the University of Manchester. He is Director of the National Institute of Health Research (NIHR) Manchester Biomedical Research Centre (BRC). ). Manchester BRC seeks to address the major causes of health inequity across our diverse urban, rural and coastal settings by providing infrastructure to support early translational research in Greater Manchester, Lancashire and South Cumbria with a focus on delivering ‘personalised health and care for all’.
    Professor Bruce qualified in medicine from Queen’s University Belfast in 1988 and gained his MRCP in 1991. He trained in medicine and rheumatology in Northern Ireland and completed his MD thesis on the pathogenesis of systemic vasculitis in 1995. He was the Geoff Carr Lupus Fellow at the University of Toronto with Murray Urowitz and Dafna Gladman (1996-98) before moving to Manchester in 1998.
    He is former Chair of the Systemic Lupus International Collaborating Clinics (SLICC) group and a member of the British Isles Lupus Assessment Group (BILAG). He leads the BILAG Biologics Register for SLE and is Chief Investigator on the SLICC/LFA/ACR Damage Index Renewal Project. He is Chair of the Astra Zeneca Anifrolumab in SLE Global Steering Group.
    Professor Bruce’s research is focused on the association between inflammatory rheumatic diseases and premature atherosclerosis/coronary heart disease as well as personalised medicine in SLE.
    Research & Clinical Focus

    SLE

    Outcomes

    Damage

    Personalised Medicine

    Atherosclerosis

    • Date Time Room Session Title Lecture Title
    May 19 16:00-16:30 Room Auditorium [Plenary Session 4] Practical Treatment Issues How do we minimise the risk of damage when managing SLE patients?
    May 19 17:00-17:20 Room Auditorium [Concurrent Session 7] Pregnancy and Reproductive Issues Use of SLE therapies in the pre-conceptual and pregnant SLE patient